Medication adherence and its determinants among patients on concomitant tuberculosis and antiretroviral therapy in south west Ethiopia

North American Journal of Medical Sciences

Volumn 4, Issue 2, 2012, Pages 67-71

  Kebede, Abebe ^a   Wabe, Nasir Tajure ^a  

^a JIMMA UNIVERSITY   (Ethiopia)

Author keywords

Comorbidity; Ethiopia; Health literacy; Medications adherence

Indexed keywords

ANTIRETROVIRUS AGENT; TUBERCULOSTATIC AGENT;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; ARTICLE; CLINICAL ARTICLE; COMORBIDITY; CONCURRENT INFECTION; CROSS-SECTIONAL STUDY; DRUG DOSE REGIMEN; EDUCATIONAL STATUS; ETHIOPIA; FEMALE; HEALTH CARE PERSONNEL; HEALTH LITERACY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; MALE; MONEY; PATIENT COMPLIANCE; QUESTIONNAIRE; TUBERCULOSIS;

EID: 84857860684     PISSN: None     EISSN: 19472714     Source Type: Journal    
DOI: 10.4103/1947-2714.93376     Document Type: Article

References (18)

1. Corbett E, Watt C, Waler N, Maher D, Williams B, Raviglione M, et al. The growing burden of TB: Global trends and interactions with the HIV epidemic. Arch Intern Med 2003;163:1009-1021.
2. Soumya S, Gopalan N, Perumal V, Sheik I, Rameshkumar S, Pradeep A, et al. Efficacy of a 6-month versus 9-month intermittent treatment regimen in HIV-infected patients with tuberculosis: A randomized clinical trial. Am J Respir Crit Care Med 2010;181:743-751.
3. th ed.; 2008. p. 34-49.
4. Bartlett JA. Addressing the challenges of adherence. J Acquir Immune Defc Syndr 2002;29 Suppl 1:S2-S10.
5. Lange JM, Perriens J, Kuritzkes D, Zewdie D. What policymakers should know about drug resistance and adherence in the context of scaling-up treatment of HIV infection. AIDS 2004;18 Suppl 3:S69-S74.
6. Mombasa ART project. Adherence to antiretroviral therapy in adults: A guide for trainers. Kenya: Horizons/Population Council; 2004. p. 281-289.
7. Ickvics J, Meads C. Adherence to HAART among patients with HIV: Break through and barriers. AIDS Care 2002;14: 309-318.
8. Rocha M, Pereira S, Ferreira L, Barros H. The role of adherence in tuberculosis HIV-positive patients treated in ambulatory regimen. Eur Respir J 2003;21:785-788.
9. Gothi D, Joshi JM. Clinical and laboratory observations of TB at a Mumbai (India) clinic. Postgrad Med J 2004;80:97-100.
10. Beyene KA, Gedif T, Gebre-Mariam T, Engidawork E. Highly active antiretroviral therapy adherence and its determinants in selected hospitals from south and central Ethiopia. Pharmacoepidemiol Drug Saf 2009;18:1007-1015.
11. Cauldbeck MB, O'Connor C, O'Connor MB, Saunders JA, Rao B, Mallesh VG, et al. Adherence to anti-retroviral therapy among HIV patients in Bangalore, India. AIDS Res Ther 2009;6:7.
12. Orell C. ART adherence in resource poor setting. Curr HIV/ AIDS Rep 2005;2:171-176.
13. Monica GA, Paul KF, Richard OA, Joan NK. Non adherence to anti-TB drugs among TB/HIV co-infected patients in Mibarara Hospital Uganda: Prevalence and associated factors. Afr Health Sci 2009;9:8-15.
14. Mukherjee JS, Ivers L, Leandre F, Farmer P, Behforouz H. Antiretroviral therapy in resource-poor settings. Decreasing barriers to access and promoting adherence. J Acquir Immune Defc Syndr 2006;43 Suppl 1:S123-S126.
15. Lanièce I, Ciss M, Desclaux A, Diop K, Mbodj F, Ndiaye B, et al. Adherence to HAART and its principal determinants in a cohort of Senegalese adults. AIDS 2003;17 Suppl 3:S103-S108.
16. Nachega JB, Stein DM, Lehman DA, Hlatshwayo D, Mothopeng R, Chaisson RE, et al. Adherence to antiretroviral therapy in HIV-infected adults in Soweto, South Africa. AIDS Res Hum Retroviruses 2004;20:1053-1056.
17. Okuno J, Yanagi H, Tomura S. Is cognitive impairment a risk factor for poor compliance among Japanese elderly in the community? Eur J Clin Pharmacol 2001;57:589-594.
18. Waus D, Singhs AK. Non adherence to TB treatment in the eastern Tarai Nepal. Int J Tuberc Lung Dis 2003;7:327-331.